RCC-36 FREE BASE

Details

Stereochemistry	RACEMIC
Molecular Formula	C22H31NO3
Molecular Weight	357.4864
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCNCC#CC(C)(C)OC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2

InChI

InChIKey=BWTHWMSRTKTAFC-UHFFFAOYSA-N

InChI=1S/C22H31NO3/c1-4-23-17-11-16-21(2,3)26-20(24)22(25,18-12-7-5-8-13-18)19-14-9-6-10-15-19/h5,7-8,12-13,19,23,25H,4,6,9-10,14-15,17H2,1-3H3

HIDE SMILES / InChI

Molecular Formula	C22H31NO3
Molecular Weight	357.4864
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: Gillenwater Jay Young, Adult and Pediatric Urology, V. 1, p. 1156, retrieved from: https://books.google.ru/books?id=sCsqHg0ljoIC&pg=PA1156&lpg=PA1156&dq=TEMIVERINE+Overactive+bladder&source=bl&ots=pvonWET1Iv&sig=ACfU3U3ocEQUNo-wzEWQce88b8UTEQ4ayw&hl=ru&sa=X&ved=2ahUKEwiqxd_Z5qfjAhWPIZoKHSUgBh4Q6AEwEnoECAgQAQ#v=onepage&q=TEMIVERINE%20Overactive%20bladder&f=false | https://www.ncbi.nlm.nih.gov/pubmed/9624560

Temiverine was developed as an antimuscarinic and calcium-antagonist agent for the treatment of overactive bladder. Temiverine participated in clinical trials; however, the development of the drug was discontinued on the pre-registration stage.

Approval Year

PubMed

Title	Date	PubMed

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 04:54:25 GMT 2023` Edited by `admin` on `Sat Dec 16 04:54:25 GMT 2023`
Record UNII	3FR9R1IKCO
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

RCC-36 FREE BASE

Code

English

(±)-4-ETHYLAMINO-1,1-DIMETHYLBUT-2-YN-1-YL 2-CYCLOHEXYL-2-HYDROXY-2-PHENYLACETATE

Systematic Name

English

BENZENEACETIC ACID, .ALPHA.-CYCLOHEXYL-.ALPHA.-HYDROXY-, 4-(ETHYLAMINO)-1,1-DIMETHYL-2-BUTYN-1-YL ESTER

Common Name

English

Code System Code Type Description

CAS

146205-91-6

Created by admin on Sat Dec 16 04:54:25 GMT 2023 , Edited by admin on Sat Dec 16 04:54:25 GMT 2023

PRIMARY

PUBCHEM

154340

Created by admin on Sat Dec 16 04:54:25 GMT 2023 , Edited by admin on Sat Dec 16 04:54:25 GMT 2023

PRIMARY

FDA UNII

3FR9R1IKCO

Created by admin on Sat Dec 16 04:54:25 GMT 2023 , Edited by admin on Sat Dec 16 04:54:25 GMT 2023

PRIMARY

Related Record Type Details


					0FUM3H8670

RCC-36

SALT/SOLVATE -> PARENT

Amount:

Related Record Type Details


					A6H0R92B1B

TEMIVERINE

PARENT -> METABOLITE ACTIVE

Amount: